Calcilytix Therapeutics Revenue and Competitors
Claim your profile
Estimated Revenue & Valuation
- Calcilytix Therapeutics's estimated annual revenue is currently $2.3M per year.
- Calcilytix Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Calcilytix Therapeutics has 15 Employees.
- Calcilytix Therapeutics grew their employee count by 150% last year.
Calcilytix Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $1.1M | 7 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 150% | N/A | N/A |
#5 | $1.4M | 9 | 0% | N/A | N/A |
#6 | $11.5M | 74 | -12% | N/A | N/A |
#7 | $0.4M | 275 | 10% | $236.7M | N/A |
#8 | $4M | 51 | -74% | $160M | N/A |
#9 | $2.5M | 16 | 33% | N/A | N/A |
#10 | $3.3M | 21 | -12% | N/A | N/A |
What Is Calcilytix Therapeutics?
Calcilytix Therapeutics, an affiliate of BridgeBio Pharma, is a clinical-stage biopharmaceutical company focused on developing a targeted therapy for disorders of calcium homeostasis. Our product candidate, encaleret, is an investigational orally-administered small molecule designed to specifically inhibit the calcium-sensing receptor, hypothesized to restore normal serum calcium and lower urine calcium.
keywords:N/A
N/A
Total Funding
15
Number of Employees
$2.3M
Revenue (est)
150%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.4M | 15 | 0% | $100M |
#2 | $1.4M | 15 | -17% | N/A |
#3 | $1.3M | 15 | 0% | N/A |
#4 | $0.5M | 15 | -6% | $34M |
#5 | $0.4M | 15 | -42% | $156.1M |